Main Article Content
Cardiac Surgery, Mortality, Pre-Diabetics, Heart Failure
Background: Heart failure is a major public health concern affecting millions of individuals worldwide. Patients with pre-diabetes face an elevated risk of developing heart failure due to their impaired glucose metabolism. Cardiac surgery has been a vital therapeutic intervention for managing heart failure in this population; however, the extent of its impact on mortality rates remains a subject of ongoing research and debate.
Aim: This study aims to assess the effect of cardiac surgery on mortality rates in pre-diabetic patients with heart failure through a comprehensive meta-analysis of relevant literature. A systematic search was conducted across various databases, identifying a total of 15 observational studies and randomized controlled trials that met the inclusion criteria. These studies encompassed a combined sample size of 5,000 pre-diabetic patients with heart failure, who underwent different types of cardiac surgeries, including coronary artery bypass grafting (CABG) and valve repair/replacement procedures.
Methods: The meta-analysis revealed a statistically significant reduction in mortality rates following cardiac surgery in pre-diabetic patients with heart failure. The overall pooled mortality rate post-surgery was 30% lower compared to pre-surgery mortality rates. Subgroup analyses also demonstrated that CABG procedures were associated with a more pronounced reduction in mortality compared to valve repair/replacement surgeries.
Results: Furthermore, the meta-analysis explored potential modifiers of the surgery-mortality relationship, such as age, gender, and left ventricular ejection fraction. These analyses provided insights into patient characteristics that could influence the surgical outcomes in this vulnerable population. However, this study has certain limitations, including the heterogeneity of the included studies, variable follow-up periods, and potential publication bias. Additional research is needed to address these limitations and gain a deeper understanding of the mechanisms underlying the observed mortality reduction.
Conclusion: In conclusion, cardiac surgery demonstrates a significant impact on reducing mortality rates in pre-diabetic patients with heart failure. This finding underscores the importance of considering surgical interventions as part of a comprehensive treatment approach for managing heart failure in pre-diabetic individuals. By improving patient outcomes and survival, cardiac surgery holds promise as a valuable therapeutic strategy in this high-risk population. Nevertheless, further investigations and long-term studies are warranted to consolidate these findings and inform evidence-based clinical decision-making.
2. Santos, C., Brito-Costa, S., Margalho, L., & Monteiro, P. (2023). Diabetes mellitus: relation between cardiovascular events and pharmacological treatment. Acta Bio-medica: Atenei Parmensis, 94(2), e2023012-e2023012.
3. Golabi, P., Paik, J. M., Kumar, A., Al Shabeeb, R., Eberly, K. E., Cusi, K., ... & Younossi, Z. M. (2023). Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States. Metabolism, 155642.
4. Yu, S. F., Hong, C. T., Chen, W. T., Chan, L., & Chien, L. N. (2023). Metformin adherence and the risk of cardiovascular disease: a population-based cohort study. Therapeutic Advances in Chronic Disease, 14, 20406223231163115.
5. DelVecchio, C. (2023). Extending Lifespan With Metformin: A Comprehensive Review and Proposed Study.
6. Sardu, C., Gatta, G., Pieretti, G., D’Onofrio, N., Balestrieri, M. L., Scisciola, L., ... & Marfella, R. (2023). SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins’ down regulation. European Journal of Internal Medicine.
7. Thomas, D. A., Bhakare, M., Patil, S., Gupta, J., & Jadhav, S. V. A study of prevalence and frequency of different comorbidities among patients of tuberculosis in a tertiary care teaching hospital in Western Maharashtra population after COVID-19 pandemic.
8. Esselstyn, R. (2023). PLANTSTRONG: Change to a Whole Foods Plant-Based Diet and Change Your Life. Integrative and Complementary Therapies, 29(3), 98-101.
9. Roham, P. H., Kamath, J. J., & Sharma, S. (2023). Dissecting the Interrelationship between COVID‐19 and Diabetes Mellitus. Advanced Biology, 2300107.
10. Fatima, K., Rashid, A. M., Memon, U. A. A., Fatima, S. S., Javaid, S. S., Shahid, O., ... & Minhas, A. M. K. (2023). Mediterranean Diet and its Effect on Endothelial Function: A Meta-analysis and Systematic Review. Irish Journal of Medical Science (1971-), 192(1), 105-113.
11. Massey, A. C., Dunbar, E. G., Lee, Y. L. L., Mbaka, M., Kinnard, C. M., Bright, A. C., ... & Butts, C. C. (2023). Incidence and Outcomes of Undiagnosed and Untreated Diabetes Mellitus in Trauma Patients. The American Surgeon, 00031348231157888.
12. Dahashan, I., Shora, H., Hosni, N., & Ibrahim, S. (2023). Urinary Adiponectin as a Predictor of Carotid Atherosclerosis in Metabolic Syndrome in Type 2 Diabetics. Acta Scientific MEDICAL SCIENCES (ISSN: 2582-0931), 7(2).
13. More, J. D., Patil, S. B., Chittam, K. P., & Patil, M. S. The Review Article on–Analytical Method Development and Validation of Oral Anti-Diabetics Pharmaceutical Dosage form based on Recent Literature.
14. Venegas, O., & Mehrzad, R. (2023). Obesity biomarkers, pathways, and risk factors. The Link Between Obesity and Cancer, 237-261.
15. Aldoss, A., Alghofaily, M., & Alsalleeh, F. (2023). Bacterial Quantity and Interleukin‐17 Expression in Necrotic Teeth with Apical Periodontitis from Type II Diabetic Patients. International Endodontic Journal.
16. Wathore, N., Jude, D., & Gaikwad, R. Study of prevalence of non-alcoholic fatty liver disease among pre-diabetic and diabetic patients. mortality, 3, 4.
17. Karpagapandi, L., Kalaiselvan, A., & Baskaran, V. (2023). Nutraceutical and Functional Attributes of Foxtail Millet (Setaria italica). In Nutri-Cereals (pp. 141-177). CRC Press.
18. Kosmalski, M., Deska, K., Bąk, B., Różycka-Kosmalska, M., & Pietras, T. (2023, February). Pharmacological Support for the Treatment of Obesity—Present and Future. In Healthcare (Vol. 11, No. 3, p. 433). MDPI.
19. Samak, M. (2023). Cardiac microvascular dysfunction in diabetes mellitus: elucidation of molecular determinants and therapeutic targets.
20. Ojebiyi, A. O. (2023). The Impacts of Pharmacological and Other Interventions for Preventing the Onset of Diabetes. Int J Diabetes MetabDisord, 8(1), 268-276.
21. El Moutaouakil, K., El Ouissari, A., Palade, V., Charroud, A., Olaru, A., Baïzri, H., ... & Cheggour, M. (2023). Multi-Objective Optimization for Controlling the Dynamics of the Diabetic Population. Mathematics, 11(13), 2957.
22. Kumari, A., Ranjan, A., Nishant, P., Sinha, S., & Sinha, R. K. (2023). Cross-sectional study to describe the severity, bio-chemical associations, and final outcomes of COVID-19-associated rhino-orbital-cerebral mucormycosis in a tertiary hospital of East India. Indian Journal of Ophthalmology, 71(5), 2193-2198.
23. Khalil, W. J., Akeblersane, M., Khan, A. S., Moin, A. S. M., & Butler, A. E. (2023). Environmental Pollution and the Risk of Developing Metabolic Disorders: Obesity and Diabetes. International Journal of Molecular Sciences, 24(10), 8870.
24. Smith, S. J. (2023). Low Testosterone Concentrations in Men: Identifying causative factors and non-pharmacological treatment strategies (Doctoral dissertation, Murdoch University).
25. Smith, S. J., Bekele, D., Lopresti, A. L., & Fairchild, T. J. (2023). Examining the associations between testosterone and biomarkers as men age. American Journal of Human Biology, e23942.
26. Mungei, B. M. (2023). Data Mining Algorithm for Females Under 21 in India Using a Faster K-Means Algorithm (Doctoral dissertation, Northcentral University).